LynxCare

LynxCare

Hospitals and Health Care

Leuven, Flemish Region 6,797 followers

Unlocking Clinical Outcomes & Real-World Evidence at scale. Discover the Power of Precision Medical Data.

About us

Transforming Healthcare Information. LynxCare is a scale-up company in Clinical Artificial Intelligence, focused on precision medical data extraction leveraging AI and disease-specific NLP workflows. The company has a proven track record in unlocking previously unavailable clinical data for better patient care and scientific research within a strict ethical and legal framework. LynxCare is part of the CBInsights Global Digital Health 150 and recognized among the World's Best Digital Health companies by Newsweek and Statista.

Website
https://lynx.care
Industry
Hospitals and Health Care
Company size
11-50 employees
Headquarters
Leuven, Flemish Region
Type
Privately Held
Founded
2016
Specialties
Clinical Data Warehouse, NLP, Real World Evidence, PROMS, Quality indicators, clinical data coding ( SNOMED ), outcome data collection, Natural Language Processing, Text Mining, Patient Empowerment, OMOP, EHDEN, RWE, OHDSI, Interoperability, EHDS, FAIR data, Life sciences research, Artificial Intelligence, AI, Real-World Evidence, and Darwin-EU

Locations

Employees at LynxCare

Updates

  • LynxCare reposted this

    View profile for Dries Hens , M.D., graphic

    Unlocking clinical outcomes and real world evidence, at scale

    🚀 Exciting Times Ahead in Healthcare Data! 🚀 As we enter a new era of healthcare innovation with the European Health Data Space (EHDS), ensuring the quality of our datasets is more critical than ever. That’s why I’m incredibly excited to introduce LynxCare Sentinel – the game-changing framework designed to empower hospitals and healthcare providers to ensure their EHR-derived datasets are of the highest quality! With Sentinel, hospitals can unlock the true potential of their data, enabling AI-driven insights, cutting-edge research, and innovation powered by the OMOP Common Data Model (OHDSI). It’s time to elevate data quality, drive progress, and truly harness the power of health data for better patient outcomes! 🎥 Watch the demo to see how Sentinel works and how it can transform healthcare data quality! 👉https://lnkd.in/e_uffbTA The future of healthcare data is here, and we’re just getting started. Let’s make data quality the foundation of AI and research excellence. 🚀💡 #LynxCare #Sentinel #EHDS #DataQuality #AI #HealthTech #Innovation #Healthcare #Research #OMOP #RWD #ML

  • 🩺 Exploring the #Heart-Kidney Connection in #HeartFailure. Published in ESC Heart Failure. 🚨 Chronic kidney disease (#CKD) often accompanies Heart Failure (HF), creating a complex interplay that impacts patient outcomes. Using EHRs, advanced data analytics and statistical modeling, our joint study with Heart Center Aalst examined the significance of kidney function—specifically #eGFR trajectories—in predicting mortality in HF patients. 𝐊𝐞𝐲 𝐟𝐢𝐧𝐝𝐢𝐧𝐠𝐬: ◽ CKD affects 58% of HF patients and doubles 1- and 2-year mortality rates ◽ Declines in eGFR over a year significantly increase mortality risk, underlining the importance of monitoring eGFR trends, not just baseline values. ◽ Beyond kidney function, other predictors like age, NT-proBNP levels, and comorbidities shape patient prognosis. This 𝐫𝐞𝐚𝐥-𝐰𝐨𝐫𝐥𝐝 𝐞𝐯𝐢𝐝𝐞𝐧𝐜𝐞 𝐬𝐭𝐮𝐝𝐲 highlights the potential of integrating eGFR trends into clinical assessments, paving the way for more personalized and proactive HF management. 🚨 https://lnkd.in/ef_k5sg5 - Thank you Heart Center Aalst! A̳u̳t̳h̳o̳r̳s̳: Sofie Verstreken, Monika Beles, Clara L. Oeste, Ana Moya, Imke Masuy, Riet Dierckx, Ward A. Heggermont, Jeroen Dauw, Dries Hens , M.D., Jozef Bartunek, Marc Vanderheyden #Cardiology

    • No alternative text description for this image
  • 🔍 Another powerful example of how LynxCare's precision medical data is driving collaborative scientific value in #oncology.   🎥 In this video, Danielle Delombaerde (Integrated Cancer Center Ghent) highlights the findings from our joint multi-center real-world study on immune checkpoint inhibitors, revealing a higher incidence of cardiovascular events in patients than reported in clinical trials.   💡 These insights are a game-changer for physicians, emphasizing the need to integrate real-world data with randomized clinical trial data to capture the full scope of patient outcomes. If you missed the previous video, you can watch it here: https://lnkd.in/dJGGGt_5   Thank you, MediMix and Danielle Delombaerde! #ESMO2024 #ImmunoOncology UZA AZ Maria Middelares az groeninge

    View organization page for MediMix, graphic

    1,199 followers

    🔬 Real-World CV Risks with ICIs from ESMO 2024 Danielle Delombaerde (Integrated Cancer Center Ghent) reveals a higher incidence of cardiovascular (CV) events in patients on immune checkpoint inhibitors (ICIs) compared to clinical trials. This Belgian cohort highlights the need for CV monitoring, as late-onset events like Takotsubo cardiomyopathy were seen up to 529 days post-treatment. Discover these updates.👇 For all ESMO 2024 videos, find the link in the comments! #MediMix #ESMO2024 #Oncology #Immunotherapy #Cardiotoxicity #CancerResearch

  • Good morning from #ISPOREurope 2024 - we're excited to welcome you at Booth 1126! 👋   Here's what you can explore with us: ✅ Discover our 𝐟𝐞𝐝𝐞𝐫𝐚𝐭𝐞𝐝 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐡𝐨𝐬𝐩𝐢𝐭𝐚𝐥 𝐧𝐞𝐭𝐰𝐨𝐫𝐤 ✅ Learn more about the 𝐡𝐢𝐠𝐡-𝐪𝐮𝐚𝐥𝐢𝐭𝐲 𝐩𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐦𝐞𝐝𝐢𝐜𝐚𝐥 𝐝𝐚𝐭𝐚 we unlock ✅ R̳e̳q̳u̳e̳s̳t̳ ̳a̳ ̳f̳e̳a̳s̳i̳b̳i̳l̳i̳t̳y̳ ̳s̳t̳u̳d̳y̳ - get insights on 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐜𝐨𝐮𝐧𝐭𝐬 and 𝐝𝐚𝐭𝐚 𝐜𝐨𝐦𝐩𝐥𝐞𝐭𝐞𝐧𝐞𝐬𝐬 within our network ✅ Watch a demo of our innovative disease-specific #NLP pipeline ✅ And so much more! 📢 Plus, meet our team: CEO, Jeanne; Chief Medical Officer, Dries; Principal RWE Researcher, Clara; and Clinical Project Manager, Charlotte.

    • No alternative text description for this image
  • Join us today from 10:30 to 13:30 in the poster hall at #ISPOREurope 2024!   📰 Poster: MSR10 - Enhancing Data Quality in Health Research: Performance Insights of a Clinical #NLP Algorithm for Diverse Medical Domains 📅 Date: Today - 18 November ⏰ Time: 10:30-13:30 🎤 Presented by Clara L. Oeste   Next, visit us at Booth 1126—just a few steps away from the poster hall. Discover how our #federated European hospital network can support your next study with comprehensive insights into your cohort of interest and data completeness. 

    • No alternative text description for this image
  • View organization page for LynxCare, graphic

    6,797 followers

    🔍 Learn first-hand how oncologists are generating 𝐜𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐯𝐞 𝐬𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐯𝐚𝐥𝐮𝐞 through the 𝐠𝐫𝐚𝐧𝐮𝐥𝐚𝐫 𝐩𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐝𝐚𝐭𝐚 unlocked by LynxCare.    🏥 With 𝐦𝐮𝐥𝐭𝐢-𝐮𝐬𝐞 𝐡𝐨𝐬𝐩𝐢𝐭𝐚𝐥 𝐝𝐚𝐭𝐚𝐛𝐚𝐬𝐞𝐬 capturing 𝐜𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 #oncology data, we empower physicians and researchers to drive impactful #research, accelerate insights across the full cancer patient journey, and fuel meaningful evidence-based #innovation in cancer therapies and treatment. Thank you, MediMix and Dr. Annelies Verbiest! #ESMO2024 #ImmunoOncology UZA az groeninge AZ Maria Middelares

    View organization page for MediMix, graphic

    1,199 followers

    🔍 Real-World ICI Usage and AEs in Belgium from ESMO 2024 Dr Annelies Verbiest (University Hospital Antwerp) discusses findings from a Belgian real-world analysis on ICIs across 20 cancer types. Of note, 54% of observed adverse events were pre-existing conditions rather than treatment-related, emphasizing the importance of baseline assessments. Discover these updates.👇 For all ESMO 2024 videos, find the link in the comments! #MediMix #ESMO2024 #Oncology #Immunotherapy #RealWorldEvidence #CancerResearch

  • Ready to unlock insights into your cohorts of interest and data completeness across our 𝐟𝐞𝐝𝐞𝐫𝐚𝐭𝐞𝐝 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐡𝐨𝐬𝐩𝐢𝐭𝐚𝐥 𝐧𝐞𝐭𝐰𝐨𝐫𝐤 for your next study? Dive in to explore the full potential of our data resources and drive impactful, evidence-based outcomes! ➡️ https://lnkd.in/e3VvdHUE W̳h̳a̳t̳ ̳m̳o̳r̳e̳ ̳a̳t̳ ̳B̳o̳o̳t̳h̳ ̳1̳1̳2̳6̳ ▪️ Explore recent real-world data use cases ▪️ Receive a demo of our Data Quality dashboard ánd our disease-specific #NLP technology ▪️ Meet our team: CEO, Jeanne; Chief Medical Officer, Dries; Principal RWE Researcher, Clara; and Clinical Project Manager, Charlotte #oncology #cardiology #mentalhealth #immunology

  • LynxCare reposted this

    View profile for Dries Hens , M.D., graphic

    Unlocking clinical outcomes and real world evidence, at scale

    🌍 Step into the future of healthcare data with LynxCare! Discover how our #NLP-driven solutions are reshaping clinical insights in real time—transforming unstructured physician notes into actionable, structured data, instantly ready for research and validation. In a world filled with #AI buzzwords, LynxCare has been building #NLP-powered solutions that drive real change and innovation for over 9 years. Our technology is powered by a highly powerful, yet efficient, language model that transforms raw clinical notes into the standardized #OMOP CDM format, enriching existing structured data. 🎥 Check out our short demo video and see how our NLP model, in real time, converts the unstructured data from physician notes into structured formats, ready for validation and research. Our multilingual NLP breaks down borders, empowering seamless, multi-country research. Stay tuned for our next demo on how to control data quality. Note: speech-to-text functionality is not part of our offering. Jeanne Kehren Shahbaz Pervaiz Tom Dufour Geert Van Gorp Lucas Sterckx Alina Kramchaninova Narges Far OHDSI OHDSI Belgium DedalusFrederic Jallat ESCP - MSc Biopharmaceutical Management

  • See you in Barcelona for #ISPOREurope 2024? 🌊   Join us at booth 1126 to connect with our incredible team of clinical and data science experts. Dive into our latest real-world data research projects 📊, receive a demo of our innovative #NLP technology, and discover what makes our hospital network stand out 🏥.   𝐀𝐭𝐭𝐞𝐧𝐝𝐢𝐧𝐠? 𝐋𝐞𝐭’𝐬 𝐦𝐚𝐤𝐞 𝐢𝐭 𝐡𝐚𝐩𝐩𝐞𝐧!  Secure a spot to meet us at our booth through our online calendar 📅 or send us a message. https://lnkd.in/eFyMwjWE

    • No alternative text description for this image

Similar pages

Browse jobs

Funding

LynxCare 6 total rounds

Last Round

Series A

US$ 21.1M

See more info on crunchbase